| Product Name | KDR antibody - N-terminal region |
|---|---|
| Antibody Type | Primary Antibodies |
| Immunogen | The immunogen for anti-KDR antibody: synthetic peptide directed towards the N terminal of human KDR |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| Species Reactivity | BovineDogHorseHumanPig |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Symbol | KDR |
|---|---|
| Gene Synonyms | CD309 FLK1 VEGFR VEGFR2 |
| Gene Full Name | Kinase insert domain receptor (a type III receptor tyrosine kinase) |
| Gene Summary | KDR is the receptor for VEGF or VEGFC. It has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. |
| Alternative Names | CD309 FLK1 VEGFR VEGFR2 |
| Molecular Weight(MW) | 151kDa |
| Sequence | 1356 amino acids |
| Form | Liquid |
|---|---|
| Storage Instructions | Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles |
| Storage Buffer | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
